Company environment · Targeted small molecules · multi-market
A targeted cancer pill across markets
Jobs span early trials through approval and later expansions. Start at the top to see what the company does, then the jobs AI models were given here and how each scored.
1What does this company do?
A drug company developing a targeted pill for cancer.
The company takes one medicine from early trials, through approval in the US and abroad, to a later approval for a new type of cancer.
2Where is the product on its way to patients?
The pill is approved, sold, and being extended to new uses and new countries.
- 1Discovery
- 2Lab & animal studies
- 3Human trials
- 4Filing & review
- 5Approved
- 6On the market
- The product is here
Jobs sit at different dates: early development, just after US approval, and during a later application for a new use.
3What is happening right now?
Several dated moments, each with its own decision.
Whether to ask for a faster review path early on, how to answer a foreign regulator, how to close out a round of study-plan amendments, and how to line up records on approval day.
4Which jobs were the models given?
4 jobs, each graded against a specialist’s checklist.
Scores are checks passed out of checks in the list. Each model ran each job once.
5–7Evidence, work and verdict
This company’s files stay private.
It is built from a real product’s records, so its files, runs and checklists aren’t published. To follow a job all the way down to each check, open one of the public environments.
Havenor Therapeutics (fictional, fully published) →
Broad Institute (real, public FDA record) →